Clinical Trials
87 trialsExosomes in Rectal Cancer
University of Kansas Medical Center
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
CONVERCAP
Institut Bergonié
Esophageal Cancer Risk Registry
University of Pittsburgh
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
CHA University
ELEPHAS-04
Mayo Clinic
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
DELIVER
Niguarda Hospital
Neocolon
Osijek University Hospital
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
AdventHealth
FECCO-BioBank
University Hospital, Montpellier
COCO-S
Nordsjaellands Hospital
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Stanford University
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Memorial Sloan Kettering Cancer Center
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Memorial Sloan Kettering Cancer Center
Biological Sample Repository for Gastrointestinal Disorders
Brigham and Women's Hospital
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
ADVANCED MARKER DISCOVERY S.L.
DESIR
Centre Hospitalier Universitaire de Besancon
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
PRIMO
Jena University Hospital
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Kansas State University
Pan-tumor MRD Study
Paradigm Health
ESCAPE
Erasmus Medical Center
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
University Hospital, Montpellier
AACRC
City of Hope Medical Center
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
Beth Israel Deaconess Medical Center
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
Rigshospitalet, Denmark
SERPAN
Centre Hospitalier Universitaire de Saint Etienne
FUTURE
Assistance Publique Hopitaux De Marseille
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang University
MAPLES
Imperial College London
PREVENPANC
Hospital Clinic of Barcelona
GIMICC
University Medical Center Groningen
ctDNA
Imperial College London
CAPITOL
University Hospital, Toulouse
CyGIM
University of Cambridge
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Peking University Cancer Hospital & Institute
Epigenetic Regulation of Colorectal Polyps and Cancer
Region Skane
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Mayo Clinic
The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma
University Health Network, Toronto
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
University Hospital, Montpellier
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
Northwestern University
Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy
Zhejiang Cancer Hospital
Chemerin in Colorectal Cancer and Its Relationship With Diet Quality
Hacettepe University
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
COLOFIT
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)
Eastern Hepatobiliary Surgery Hospital
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
Seoul National University Hospital
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
Seoul National University Hospital